Physician profile
Mark E Levinson
NPI 1689775611
$1,452.85
in general payments reported to CMS, 2019-2025
25 companies · $220 in 2025
The $220 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $351 · 2020: $122 · 2021: $35.36 · 2022: $269 · 2023: $109 · 2024: $346 · 2025: $220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $675.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $675.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $229.64 | 2019-2022 | |
| Abbvie INC. | $122.80 | 2019-2025 | |
| Olympus America INC. | $119.91 | 2022-2024 | Cysto-Nephro Videoscope, Itind System, Uretero-Reno Videoscope |
| Procept Biorobotics Corporation | $117.25 | 2023-2024 | Aquabeam System, Aquabeam Robotic System |
| Sumitomo Pharma America, INC. | $102.49 | 2023-2025 | Gemtesa |
| Tolmar Pharmaceuticals, INC. | $84.94 | 2019-2022 | |
| Coloplast Corp | $83.24 | 2024-2025 | |
| Tolmar, INC. | $81.24 | 2023-2024 | |
| Allergan, INC. | $78.28 | 2019 | |
| Pfizer INC. | $74.26 | 2022-2025 | |
| Endo Pharmaceuticals INC. | $46.38 | 2019 | |
| Boston Scientific Corporation | $38.25 | 2019-2022 | |
| Janssen Biotech, INC. | $33.23 | 2025 | Erleada |
| Progenics Pharmaceuticals, INC. | $28.40 | 2025 | |
| Urogen Pharma, INC. | $26.80 | 2025 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $26.29 | 2020 | |
| Laborie Medical Technologies Corp. | $26.02 | 2023 | |
| Dendreon Pharmaceuticals LLC | $24.78 | 2019 | |
| Rochester Medical Corporation | $22.17 | 2020 | |
| Cook Medical LLC | $17.44 | 2024 | Cook |
| Myovant Sciences INC. | $15.12 | 2021 | |
| Neotract INC. | $14.56 | 2020 | |
| Blue Earth Diagnostics | $14.30 | 2019 | |
| Myriad Genetic Laboratories, INC. | $12.93 | 2022 | |
| Urovant Sciences INC | $12.13 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Levinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.